Gabapentin
- Product NDC
- 0615-8340
- 11-digit product format
- 006158340
- Labeler code
- 0615
- Product ID
- 0615-8340_d113f5d6-35ad-4e03-8ccd-04db9aa7a418
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, LLC dba Vangard Labs
- Application
- ANDA078428
- Marketing category
- ANDA
- Marketing start
- 2009-11-24
- Marketing end
- 2024-05-31
- Substance
- GABAPENTIN
- Active strength
- 100 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0615-8340-05 | 00615834005 | 15 CAPSULE in 1 BLISTER PACK (0615-8340-05) | 15 capsule | 2020-06-09 | 0000-00-00 | No | No | Current |
| 0615-8340-30 | 00615834030 | 6 BLISTER PACK in 1 BOX, UNIT-DOSE (0615-8340-30) > 5 CAPSULE in 1 BLISTER PACK | 6 blister pack | 2020-06-09 | 0000-00-00 | No | No | Current |
| 0615-8340-39 | 00615834039 | 30 CAPSULE in 1 BLISTER PACK (0615-8340-39) | 30 capsule | 2020-06-09 | 0000-00-00 | No | No | Current |